Association between SGLT2 Inhibitors and Risk of Dementia and Parkinson’s Disease: A Meta-Analysis of 12 Randomized Controlled Trials

By sjmartinez • July 9, 2024

Jaiswal V, Mashkoor Y, Raj N, Rajak K, Jaiswal A, Fonarow GC. Association between SGLT2 Inhibitors and Risk of Dementia and Parkinson's Disease: A Meta-Analysis of 12 Randomized Controlled Trials. Am J Med. 2024 Jul 6:S0002-9343(24)00420-0. doi: 10.1016/j.amjmed.2024.06.030. Epub ahead of print. PMID: 38977148.

Tags: Cardiology/Epi, Dementia, diabetes mellitus, heart failure, Parkinson’s disease, Publications, SGLT2I

Acute Cardiogenic Shock Secondary to Left Main Occlusion in a Patient with Behçet Disease

Sekhon HK, Sareh S, Kellner D, Yiu G, Benharash P, Hollowed J, Shahandeh N. Acute Cardiogenic Shock Secondary to Left Main Occlusion in a Patient[...]

Early structural cardiovascular disease, HIV, and tuberculosis in East Africa (ASANTE): cross-sectional study protocol for a multimodal cardiac imaging study in Nairobi, Kenya

Shakil SS, Korir S, Omondi G, Ale BM, Gitura B, Morris M, Kinuthia J, Chohan B, Haynes N, Farquhar C, Hsue PY, Longenecker CT, Osoti[...]

Estimated Glomerular Filtration Rate Variability and Incident Heart Failure in Adults With Type 2 Diabetes

Kaze AD, Ndumele CE, Jaar BG, Santhanam P, Yeneneh BT, Mookadam F, Tung R, Fonarow GC, Crews DC, Echouffo-Tcheugui JB. Estimated Glomerular Filtration Rate Variability[...]